The recall has been issued for some products due to higher than acceptable levels of benzene, a chemical linked to leukemia and other blood disorders.

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal with Roche, go here; and to read about the panels at our Breakthrough East ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

A simple clerical error could freeze your bank accounts, cancel your health insurance, and even complicate your taxes. Here’s ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

The Unison union says the NHS trust that runs both hospitals has "repeatedly missed deadlines to correct the workers' pay".

The French captain, and Real Madrid star, openly expresses his admiration for his compatriot who maintains club legend status ...

MANCHESTER UNITED are braced for a MONUMENTAL summer transfer window – with Ruben Amorim expected to overhaul the squad with ...

Veracode’s total economic impact, a study conducted in August 2024 by Forrester Consulting, revealed that Veracode delivers a remarkable 184 percent return on investment, a net present value (NPV) of ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

The FDA said testing of certain acne products with benzoyl peroxide found elevated levels of benzene, a chemical linked to cancer.